Two Sigma Securities’s Oncolytics Biotech ONCY Stock Holding History

Two Sigma Securities’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.1K	Sell	14,862 -10,765	-42%	-$9.98K	﹤0.01%	1527
2026 Q1	$21.8K	Buy	+25,627	New	+$25.5K	﹤0.01%	1361
2025 Q2	–	Sell	-15,159	Closed	-$8.34K	–	1922
2025 Q1	$8.34K	Buy	+15,159	New	+$11.1K	﹤0.01%	1257
2024 Q4	–	Sell	-14,079	Closed	-$12.3K	–	2763
2024 Q3	$12.3K	Buy	+14,079	New	+$13.8K	﹤0.01%	2564
2024 Q2	–	Sell	-11,816	Closed	-$12.5K	–	3459
2024 Q1	$12.5K	Sell	11,816 -11,562	-49%	-$12.9K	﹤0.01%	2735
2023 Q4	$31.6K	Buy	+23,378	New	+$36.5K	﹤0.01%	2657
2022 Q3	–	Sell	-20,512	Closed	-$21K	–	2955
2022 Q2	$21K	Buy	+20,512	New	+$24.9K	﹤0.01%	1953
2022 Q1	–	Sell	-27,125	Closed	-$38K	–	2389
2021 Q4	$38K	Buy	+27,125	New	+$50.1K	﹤0.01%	1317

Other funds holding ONCY

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Two Sigma Securities's ONCY Position: Q2 2026 in Review

Two Sigma Securities reduced its Oncolytics Biotech (ONCY) stake by 42% in Q2 2026, selling an estimated $9.98K and leaving 14,862 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1527.

Two Sigma Securities first reported a position in ONCY in Q4 2021 and has held it in 8 quarters since. The position peaked at $38K in Q4 2021. 75 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

Two Sigma Securities held 14,862 shares of Oncolytics Biotech worth $14.1K as of Q2 2026.
Two Sigma Securities sold 10,765 Oncolytics Biotech shares in Q2 2026, an estimated $9.98K.
Oncolytics Biotech made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1527 holding.
Two Sigma Securities first reported a position in Oncolytics Biotech in Q4 2021 and has held it in 8 quarters since.
Two Sigma Securities's Oncolytics Biotech position peaked at $38K in Q4 2021.
75 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.